Skip to main content

Advertisement

Log in

Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy

  • Materno-fetal Medicine
  • Published:
Archives of Gynecology and Obstetrics Aims and scope Submit manuscript

Abstract

Purposes

To determine the incidence, obstetrical, and fetal complication rates of intrahepatic cholestasis of pregnancy (ICP) in patients managed expectantly to 40-weeks gestation.

Methods

In a prospective cohort study conducted between February 2008 and January 2010, a total of 21,960 pregnant women in Qassim Region of Saudi Arabia were screened for ICP using specific criteria for diagnosis. The course of pregnancy was monitored to 40-weeks gestation or spontaneous onset of labor, whichever comes first. The measured outcomes were compared with a cross-matched group of healthy pregnant women. Continuous variables were analyzed with t test, while χ2 test was used for comparing percentages.

Results

The incidence of ICP was 0.35% (76/21,960). There was no significant difference between groups in gestational age at delivery, preterm labor, intrauterine fetal death, cesarean section, or respiratory distress syndrome. There was significantly higher intrapartum non-reassuring fetal heart rate patterns and meconium-stained amniotic fluid in ICP group (P < 0.01 and <0.0001, respectively).

Conclusions

The incidence of ICP in this region is low compared to worldwide range. Expectant management to 40-weeks gestation is associated with obstetrical and fetal outcomes comparable to normal pregnancy; however, intrapartum fetal asphyxia is more likely.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Ambros-Rudolph CM, Glatz M, Trauner M, Kerl H, Müllegger RR (2007) The importance of serum bile acid level analysis and treatment with ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a case series from central Europe. Arch Dermatol 143:757–762

    Article  PubMed  CAS  Google Scholar 

  2. Ambros-Rudolph CM, Müllegger RR, Vaughan-Jones SA, Kerl H, Black MM (2006) The specific dermatoses of pregnancy revisited and reclassified: results of a retrospective two-center study on 505 pregnant patients. J Am Acad Dermatol 54:395–404

    Article  PubMed  Google Scholar 

  3. Geenes V, Williamson C (2009) Intrahepatic cholestasis of pregnancy. World J Gastroenterol 15:2049–2066

    Article  PubMed  Google Scholar 

  4. Kroumpouzos G (2002) Intrahepatic cholestasis of pregnancy: what’s new. JEADV 16:316–318

    PubMed  CAS  Google Scholar 

  5. Lee RH, Goodwin TM, Greenspoon J, Incerpi M (2006) The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. J Perinatol 26:527–532

    Article  PubMed  CAS  Google Scholar 

  6. Ruetz S, Gros P (1994) Phosphatidylcholine translocase: a physiological role for the mdr2 gene. Cell 77:1071–1081

    Article  PubMed  CAS  Google Scholar 

  7. Smith AJ, Timmermans-Hereijgers JL, Roelofsen B, Wirtz KW, van Blitterswijk WJ, Smit JJ et al (1994) The human MDR3 P-glycoprotein promotes translocation of phosphatidylcholine through the plasma membrane of fibroblasts from transgenic mice. FEBS Lett 354:263–266

    Article  PubMed  CAS  Google Scholar 

  8. Yamamoto Y, Moore R, Hess HA, Guo GL, Gonzalez FJ, Korach KS et al (2006) Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity. J Biol Chem 281:16625–16631

    Article  PubMed  CAS  Google Scholar 

  9. Rathi U, Bapat M, Rathi P, Abraham P (2007) Effect of liver disease on maternal and fetal outcome: a prospective study. Indian J Gastroenterol 26:59–63

    PubMed  Google Scholar 

  10. Kroumpouzos G, Cohen LM (2001) Dermatoses of pregnancy. J Am Acad Dermatol 45:1–19

    Article  PubMed  CAS  Google Scholar 

  11. Reyes H, Báez ME, González MC, Hernández I, Palma J, Ribalta J et al (2000) Selenium, zinc and copper plasma levels in intrahepatic cholestasis of pregnancy, in normal pregnancies and in healthy individuals, in Chile. J Hepatol 32:542–549

    Article  PubMed  CAS  Google Scholar 

  12. Reyes H, Taboada G, Ribalta J (1979) Prevalence of intrahepatic cholestasis of pregnancy in La Paz, Bolivia. J Chronic Dis 32:499–504

    Article  PubMed  CAS  Google Scholar 

  13. Shaw D, Frohlich J, Wittmann BA, Willms MA (1982) Prospective study of 18 patients with cholestasis of pregnancy. Am J Obstet Gynecol 142:621–625

    PubMed  CAS  Google Scholar 

  14. Lo TK, Lau WL, Lam HS, Leung WC, Chin RK (2007) Obstetric cholestasis in Hong Kong—local experience with eight consecutive cases. Hong Kong Med J 13:387–391

    PubMed  CAS  Google Scholar 

  15. Williamson C, Hems LM, Goulis DG, Walker I, Chambers J, Donaldson O et al (2004) Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group. BJOG 111:676–681

    Article  PubMed  Google Scholar 

  16. Bacq Y, Sapey T, Bréchot MC, Pierre F, Fignon A, Dubois F (1997) Intrahepatic cholestasis of pregnancy: a French prospective study. Hepatology 26:358–364

    Article  PubMed  CAS  Google Scholar 

  17. Glantz A, Marschall HU, Mattsson LA (2004) Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates. Hepatology 40:467–474

    Article  PubMed  Google Scholar 

  18. Laatikainen T, Ikonen E (1977) Serum bile acids in cholestasis of pregnancy. Obstet Gynecol 50:313–318

    PubMed  CAS  Google Scholar 

  19. Laatikainen T, Tulenheimo A (1984) Maternal serum bile acid levels and fetal distress in cholestasis of pregnancy. Int J Gynaecol Obstet 22:91–94

    Article  PubMed  CAS  Google Scholar 

  20. Lee RH, Kwok KM, Ingles S, Wilson ML, Mullin P, Incerpi M, Pathak B, Goodwin TM (2008) Pregnancy outcomes during an era of aggressive management for intrahepatic cholestasis of pregnancy. Am J Perinatol 25:341–345

    Article  PubMed  Google Scholar 

  21. Fisk NM, Storey GN (1988) Fetal outcome in obstetric cholestasis. Br J Obstet Gynaecol 95:1137–1143

    Article  PubMed  CAS  Google Scholar 

  22. Roncaglia N, Arreghini A, Locatelli A, Bellini P, Andreotti C, Ghidini A (2002) Obstetric cholestasis: outcome with active management. Eur J Obstet Gynecol Reprod Biol 100:167–170

    Article  PubMed  Google Scholar 

  23. Rioseco AJ, Ivankovic MB, Manzur A, Hamed F, Kato SR, Parer JT et al (1994) Intrahepatic cholestasis of pregnancy: a retrospective case-control study of perinatal outcome. Am J Obstet Gynecol 170:890–895

    PubMed  CAS  Google Scholar 

  24. Reid R, Ivey KJ, Rencoret RH, Storey B (1976) Fetal complications of obstetric cholestasis. Br Med J 1:870–872

    Article  PubMed  CAS  Google Scholar 

  25. Davies MH, da Silva RC, Jones SR, Weaver JB, Elias E (1995) Fetal mortality associated with cholestasis of pregnancy and the potential benefit of therapy with ursodeoxycholic acid. Gut 37:580–584

    Article  PubMed  CAS  Google Scholar 

  26. Morrison JJ, Rennie JM, Milton PJ (1995) Neonatal respiratory morbidity and mode of delivery at term: influence of timing of elective caesarean section. Br J Obstet Gynaecol 102:101–106

    Article  PubMed  CAS  Google Scholar 

  27. Laifer SA, Stiller RJ, Siddiqui DS, Dunston-Boone G, Whetham JC (2001) Ursodeoxycholic acid for the treatment of intrahepatic cholestasis of pregnancy. J Matern Fetal Med 10:131–135

    PubMed  CAS  Google Scholar 

  28. Diaferia A, Nicastri PL, Tartagni M, Loizzi P, Iacovizzi C, Di Leo A (1996) Ursodeoxycholic acid therapy in pregnant women with cholestasis. Int J Gynaecol Obstet 52:133–140

    Article  PubMed  CAS  Google Scholar 

  29. Royal College of Obstetricians and Gynaecologists (2001) The use of electronic fetal monitoring. The use and interpretation of cardiotocography in intrapartum fetal surveillance. Evidence based clinical guideline 8

  30. Nordstrom L, Marcus C, Persson B, Shimojod N, Westgren M (1996) Lactate in cord blood and its relationship to pH and catecholamines in spontaneous vaginal deliveries. Early Hum Dev 46:97–104

    Article  PubMed  CAS  Google Scholar 

  31. American College of Obstetricians and Gynecologists (2006) Postpartum hemorrhage. ACOG Practice Bulletin No. 76

  32. Heinonen S, Kirkinen P (1999) Pregnancy outcome with intrahepatic cholestasis. Obstet Gynecol 94:189–193

    Article  PubMed  CAS  Google Scholar 

  33. Kauppila A, Korpela H, Mäkilä UM, Yrjänheikki E (1987) Low serum selenium concentration and glutathione peroxidase activity in intrahepatic cholestasis of pregnancy. Br Med J (Clin Res Ed) 294:150–152

    Article  Google Scholar 

  34. Heikkinen J, Mäentausta O, Ylöstalo P, Jänne O (1981) Changes in serum bile acid concentrations during normal pregnancy, in patients with intrahepatic cholestasis of pregnancy and in pregnant women with itching. Br J Obstet Gynaecol 88:240–245

    Article  PubMed  CAS  Google Scholar 

  35. Porembka DT, Kier A, Sehlhorst S, Boyce S, Orlowski JP, Davis K Jr (1993) The pathophysiologic changes following bile aspiration in a porcine lung model. Chest 104:919–924

    Article  PubMed  CAS  Google Scholar 

  36. Sepúlveda WH, González C, Cruz MA, Rudolph MI (1991) Vasoconstrictive effect of bile acids on isolated human placental chorionic veins. Eur J Obstet Gynecol Reprod Biol 42:211–215

    Article  PubMed  Google Scholar 

  37. Miller PW, Coen RW, Benirschke K (1985) Dating the time interval from meconium passage to birth. Obstet Gynecol 66:459–462

    PubMed  CAS  Google Scholar 

  38. Campos GA, Guerra FA, Israel EJ (1986) Effects of cholic acid infusion in fetal lambs. Acta Obstet Gynecol Scand 65:23–26

    Article  PubMed  CAS  Google Scholar 

  39. Falconer JD, Smith AN, Eastwood MA (1980) The effects of bile acids on colonic motility in the rabbit. Q J Exp Physiol Cogn Med Sci 65:135–144

    PubMed  CAS  Google Scholar 

  40. Williamson C, Gorelik J, Eaton BM, Lab M, de Swiet M, Korchev Y (2001) The bile acid taurocholate impairs rat cardiomyocyte function: a proposed mechanism for intrauterine fetal death in obstetric cholestasis. Clin Sci (Lond) 100:363–369

    Article  CAS  Google Scholar 

Download references

Conflict of interest statement

The authors have no a financial relationship with organizations that sponsored the research or any conflict of interest to be declared.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hossam O. Hamed.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Al Shobaili, H.A., Hamed, H.O., Al Robaee, A. et al. Obstetrical and fetal outcomes of a new management strategy in patients with intra-hepatic cholestasis of pregnancy. Arch Gynecol Obstet 283, 1219–1225 (2011). https://doi.org/10.1007/s00404-010-1506-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00404-010-1506-1

Keywords

Navigation